Medical News

RSS

Intracranial endovascular procedures will grow at over 5% through 2014 in the US, says MRG

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, intracranial endovascular procedures to treat aneurysms will grow at over 5% through 2014 in the US. MRG's new US Markets for Transcatheter Embolization and Occlusion Devices 2010 report finds that technological advancements in embolization coils as well as imaging and coiling-assist technology will continue to drive growth in aneurysm coiling procedures.

3 Dec 2009

Researchers to publish a paper on the availability of 'Spice' drugs online

A paper to be published this month by University of Hertfordshire researchers about the availability of 'Spice' drugs online will raise new concerns about its mood altering effects.

3 Dec 2009

Cephalon's lawsuit against Teva Pharmaceuticals for patent infringement of NUVIGIL tablets

Cephalon, Inc. today announced that it has filed a lawsuit in U.S. District Court in Delaware against Teva Pharmaceuticals USA, Inc. for infringement of U.S. Patent Nos. 7,132,570 (the "'570 Patent"), 7,297,346 (the "'346 Patent") and RE37,516 (the "'516 Patent") for the Cephalon product NUVIGIL® (armodafinil) Tablets [C-IV].

3 Dec 2009

Majority of Australians accept teen drinking

Half of Australian adults and 63 per cent of Australians on a higher income believe 15 to 17 year olds should be allowed to consume alcohol under parental supervision at home, according to the latest MBF Healthwatch survey.

3 Dec 2009

Yale researchers survey door-to-balloon times in 831 hospitals

Healthcare professionals using new time-saving strategies to coordinate care for patients having a heart attack saw dramatic improvement in "door-to-balloon" (D2B) times-the time from when a patient enters the hospital to the time blood flow is restored to the heart by opening a blockage with angioplasty. The faster patients are treated, the more likely they are to survive. The results are published by Yale researchers and their colleagues in the December 15 issue of the Journal of the American College of Cardiology.

3 Dec 2009

FDA grants Fast Track designation for Keryx Biopharmaceuticals' KRX-0401

Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for KRX-0401 (perifosine), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits the phosphoinositide 3-kinase (PI3K)/Akt pathway, for the treatment of relapsed/refractory multiple myeloma.

3 Dec 2009

Earlier diagnosis of cancer saves 5,000 to 10,000 lives each year, says Professor Mike Richards

Earlier diagnosis of people with cancer could save between 5,000 and 10,000 lives each year, Professor Mike Richards, the National Cancer Director for England, has claimed.

3 Dec 2009

Sepsis, a serious infection, remains a major threat to 'late preterm' infants

Sepsis is a serious infection that is a major cause of death in very premature infants. But sepsis is also a threat in "late preterm" infants born just a few weeks prematurely, according to a study in the December issue of The Pediatric Infectious Disease Journal. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, and pharmacy.

3 Dec 2009

New study reveals smokeless tobacco products contain high levels of cancer-causing substances

A new study on the smokeless tobacco product called moist snuff - placed between lip and gum - has led scientists in Minnesota to urge the tobacco industry to change manufacturing practices to reduce snuff's content of carcinogens.

3 Dec 2009

Beta 2 adrenergic agonist drugs linked to autism-spectrum disorders

Commonly prescribed beta 2 adrenergic agonist drugs for the treatment of asthma in pregnant women as well as pre-term labor may increase the incidence of autism-spectrum disorders, psychiatric pathology, cognitive problems and poor school performance in their children, according to a new study published in the December 2009 issue of the American Journal of Obstetrics & Gynecology.

3 Dec 2009

Exercise remains one of the most effective interventions for peripheral artery disease

Peripheral artery disease (PAD) affects 5 million individuals in the U.S. and is the leading cause of limb amputations. Doctors have long considered exercise to be the single best therapy for PAD, and now a new study helps explain why. Led by researchers at Beth Israel Deaconess Medical Center and published in this week's Online Early Edition of the Proceedings of the National Academy of Sciences (PNAS), the findings demonstrate that a protein called PGC-1alpha plays a key role in the process.

3 Dec 2009

The Hill examines push to get more U.S. funding for malaria medicines

The Hill examines Medicines for Malaria Venture's (MMV) efforts to get more U.S. funding for its work. According to the newspaper, the group is "asking USAID and Congress to redirect more money beginning next year to drug research and development from a pot of funds used to cover the range of efforts to treat and prevent malaria, such as providing mosquito nets."

3 Dec 2009

Fitness levels linked to higher IQ in young adults

Young adults who are fit have a higher IQ and are more likely to go on to university, reveals a major new study carried out at the Sahlgrenska Academy and Sahlgrenska University Hospital.

3 Dec 2009

U.S. H1N1 cases decreasing, CDC says; HHS to review approach to health-threat preparedness

The number of H1N1 (swine flu) cases in the U.S. appears to be decreasing, the CDC said Tuesday, CQ HealthBeat reports. "Flu was widespread in 32 states by the end of the week of Nov. 21, a decrease from 43 states in the prior week and 46 states earlier this fall, according to the CDC," the news service writes. "

3 Dec 2009

PanGenex capitalize on the immune-boosting properties of Spirulina

PanGenex Corporation, a global nutraceutical and dietary supplement manufacturer and marketer, announced today that the Company is actively identifying new product development opportunities that will initially focus on the immune-boosting properties of Spirulina.

3 Dec 2009

Guidelines to diagnose and manage complicated skin and soft tissue infections published

New evidence-based recommendations developed by the Surgical Infection Society to guide physicians in the diagnosis and management of complicated skin and soft tissue infections have been published in Surgical Infections, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com).

3 Dec 2009

Senate debate moving slowly, Reid could extend session

As debate over health care reform legislation continues in the Senate, Democrats are accusing Republicans of delaying votes and strategizing over how the schedule could unfold in the coming weeks.

2 Dec 2009

PPD introduces new centralized computing platform for analysis and reporting of clinical trial data

PPD, Inc. today announced it has launched a new global information technology infrastructure for analysis and reporting of clinical trial data. The biostatistics technology infrastructure (BTI) is a centralized computing platform that enhances the company’s ability to deliver secure, quality reporting and data analysis to meet client timelines.

2 Dec 2009

Impax Laboratories acquires ANDA from Watson Pharmaceuticals and Cobalt Laboratories

Impax Laboratories, Inc. today announced it acquired Abbreviated New Drug Applications (ANDA) from Watson Pharmaceuticals and Cobalt Laboratories, a subsidiary of Arrow Group.

2 Dec 2009

Repeated use of ecstasy drug increases the risk of developing sleep apnea

Repeated use of the drug popularly known as "ecstasy" significantly raises the risk of developing sleep apnea in otherwise healthy young adults with no other known risk factors for the sleep disturbance, a new study by Johns Hopkins scientists suggests.

2 Dec 2009

Medical News

Intracranial endovascular procedures will grow at over 5% through 2014 in the US, says MRG

Researchers to publish a paper on the availability of 'Spice' drugs online

Cephalon's lawsuit against Teva Pharmaceuticals for patent infringement of NUVIGIL tablets

Majority of Australians accept teen drinking

Yale researchers survey door-to-balloon times in 831 hospitals

FDA grants Fast Track designation for Keryx Biopharmaceuticals' KRX-0401

Earlier diagnosis of cancer saves 5,000 to 10,000 lives each year, says Professor Mike Richards

Sepsis, a serious infection, remains a major threat to 'late preterm' infants

New study reveals smokeless tobacco products contain high levels of cancer-causing substances

Beta 2 adrenergic agonist drugs linked to autism-spectrum disorders

Exercise remains one of the most effective interventions for peripheral artery disease

The Hill examines push to get more U.S. funding for malaria medicines

Fitness levels linked to higher IQ in young adults

U.S. H1N1 cases decreasing, CDC says; HHS to review approach to health-threat preparedness

PanGenex capitalize on the immune-boosting properties of Spirulina

Guidelines to diagnose and manage complicated skin and soft tissue infections published

Senate debate moving slowly, Reid could extend session

PPD introduces new centralized computing platform for analysis and reporting of clinical trial data

Impax Laboratories acquires ANDA from Watson Pharmaceuticals and Cobalt Laboratories

Repeated use of ecstasy drug increases the risk of developing sleep apnea

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Latest News